At the time of CRS/HIPEC, 9 patients had residual adenocarcinoma, 2 had persistent LAMN, 1 had persistent low-grade carcinoma peritonei, and 6 had only fibrous tissue or acellular mucin remaining. This evidence concerns the gene MUC5AC and adenocarcinoma.